SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: F. Jay Abella, III who wrote (4170)5/15/1998 12:10:00 PM
From: Diamondcutter  Read Replies (3) of 7041
 
The time needed to file the FDA is a concern to me. Isn't Pharmaco (sp?), the number crunching firm for ZONA, a pretty large and respected organization--and therefore one which would be expected to format the application in a "style" agreeable to SGP the first time?

FJA, I don't understand the "onset" issue. Are you indicating there is some problem with the time to react for Vasomax? Or just unhappy that the time data is not in print? If the CEO says its in the white paper and its not, that is one thing, but it is more important to know the data.

FYI, rumors still exist that SGP is limiting what ZONA can say publicly for competitive reasons. Obviously, bears will say this is not true because they can't comment favorably on a product which doesn't work (HA! beat you to it). However if the "muzzle" theory is true, it could explain why there is a limited flow of positive news

Also, there is a report that 1/3 of Viagra users desensitize to the product after about a year of use. Any medical comments regarding this and whether the same would happen for Vasomax?

Diamondcutter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext